#China has completed its clinical research on #Favilavir, an antiviral drug for #COVID19. The drug has shortened fever time for #COVID19 patients from 4.2 days to 2.5 days with no adverse reactions, a Ministry of Science and Technology official said on Tuesday. [17.03.2020]